<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Keita D</submitter><funding>European Commission FP7</funding><funding>Wellcome Trust</funding><pagination>727-36</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3101891</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>African swine fever virus (ASFV) is the unique member of the Asfarviridae family and Asfivirus genus. It is an enveloped double-stranded DNA arbovirus that replicates in the cell cytoplasm, similar to poxviruses. There is no vaccine and no treatment available to control this virus.&lt;h4>Methods&lt;/h4>We describe the use of small interfering RNA (siRNA) targeting the A151R and VP72 (B646L) genes to control the ASFV replication in vitro.&lt;h4>Results&lt;/h4>Results suggest that siRNA targeting the A151R and VP72 genes can reduce both the virus replication and its levels of messenger RNA transcripts. The reduction was up to 4 log(10) copies on the virus titre and up to 3 log(10) copies on virus RNA transcripts levels. The combination of multiple siRNA did not improve the antiviral e</pubmed_abstract><journal>Antiviral therapy</journal><pubmed_title>Control of African swine fever virus replication by small interfering RNA targeting the A151R and VP72 genes.</pubmed_title><pmcid>PMC3101891</pmcid><funding_grant_id>075813</funding_grant_id><funding_grant_id>AHDW/03/04</funding_grant_id><funding_grant_id>FP7_211691</funding_grant_id><pubmed_authors>Heath L</pubmed_authors><pubmed_authors>Albina E</pubmed_authors><pubmed_authors>Keita D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Control of African swine fever virus replication by small interfering RNA targeting the A151R and VP72 genes.</name><description>&lt;h4>Background&lt;/h4>African swine fever virus (ASFV) is the unique member of the Asfarviridae family and Asfivirus genus. It is an enveloped double-stranded DNA arbovirus that replicates in the cell cytoplasm, similar to poxviruses. There is no vaccine and no treatment available to control this virus.&lt;h4>Methods&lt;/h4>We describe the use of small interfering RNA (siRNA) targeting the A151R and VP72 (B646L) genes to control the ASFV replication in vitro.&lt;h4>Results&lt;/h4>Results suggest that siRNA targeting the A151R and VP72 genes can reduce both the virus replication and its levels of messenger RNA transcripts. The reduction was up to 4 log(10) copies on the virus titre and up to 3 log(10) copies on virus RNA transcripts levels. The combination of multiple siRNA did not improve the antiviral e</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010</publication><modification>2025-04-26T04:26:06.338Z</modification><creation>2019-06-05T16:29:44Z</creation></dates><accession>S-EPMC3101891</accession><cross_references><pubmed>20710054</pubmed><doi>10.3851/IMP1593</doi><doi>10.3851/imp1593</doi></cross_references></HashMap>